Correlation Between Mersana Therapeutics and Mustang Bio
Can any of the company-specific risk be diversified away by investing in both Mersana Therapeutics and Mustang Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mersana Therapeutics and Mustang Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mersana Therapeutics and Mustang Bio, you can compare the effects of market volatilities on Mersana Therapeutics and Mustang Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mersana Therapeutics with a short position of Mustang Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mersana Therapeutics and Mustang Bio.
Diversification Opportunities for Mersana Therapeutics and Mustang Bio
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Mersana and Mustang is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Mersana Therapeutics and Mustang Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mustang Bio and Mersana Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mersana Therapeutics are associated (or correlated) with Mustang Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mustang Bio has no effect on the direction of Mersana Therapeutics i.e., Mersana Therapeutics and Mustang Bio go up and down completely randomly.
Pair Corralation between Mersana Therapeutics and Mustang Bio
Given the investment horizon of 90 days Mersana Therapeutics is expected to under-perform the Mustang Bio. In addition to that, Mersana Therapeutics is 1.3 times more volatile than Mustang Bio. It trades about -0.19 of its total potential returns per unit of risk. Mustang Bio is currently generating about -0.19 per unit of volatility. If you would invest 1,452 in Mustang Bio on October 24, 2024 and sell it today you would lose (897.00) from holding Mustang Bio or give up 61.78% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mersana Therapeutics vs. Mustang Bio
Performance |
| Timeline |
| Mersana Therapeutics |
| Mustang Bio |
Mersana Therapeutics and Mustang Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mersana Therapeutics and Mustang Bio
The main advantage of trading using opposite Mersana Therapeutics and Mustang Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mersana Therapeutics position performs unexpectedly, Mustang Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mustang Bio will offset losses from the drop in Mustang Bio's long position.| Mersana Therapeutics vs. Terns Pharmaceuticals | Mersana Therapeutics vs. Amylyx Pharmaceuticals | Mersana Therapeutics vs. Acumen Pharmaceuticals | Mersana Therapeutics vs. Inozyme Pharma |
| Mustang Bio vs. Checkpoint Therapeutics | Mustang Bio vs. Reviva Pharmaceuticals Holdings | Mustang Bio vs. Fortress Biotech Pref | Mustang Bio vs. Kodiak Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |